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AbstrACt
Objectives To compare the characteristics of populations 
admitted to hospital-at-home services with the population 
admitted to hospital and assess the association of these 
services with healthcare costs and mortality.
Design In a retrospective observational cohort study 
of linked patient level data, we used propensity score 
matching in combination with regression analysis.
Participants Patients aged 65 years and older admitted 
to hospital-at-home or hospital.
Interventions Three geriatrician-led admission avoidance 
hospital-at-home services in Scotland.
Outcome measures Healthcare costs and mortality.
results Patients in hospital-at-home were older and more 
socioeconomically disadvantaged, had higher rates of previous 
hospitalisation and there was a greater proportion of women 
and people with several chronic conditions compared with 
the population admitted to hospital. The cost of providing 
hospital-at-home varied between the three sites from £628 to 
£2928 per admission. Hospital-at-home was associated with 
18% lower costs during the follow-up period in site 1 (ratio 
of means 0.82; 95% CI: 0.76 to 0.89). Limiting the analysis to 
costs during the 6 months following index discharge, patients 
in the hospital-at-home cohorts had 27% higher costs (ratio 
of means 1.27; 95% CI: 1.14 to 1.41) in site 1, 9% (ratio of 
means 1.09; 95% CI: 0.95 to 1.24) in site 2 and 70% in site 
3 (ratio of means 1.70; 95% CI: 1.40 to 2.07) compared with 
patients in the control cohorts. Admission to hospital-at-home 
was associated with an increased risk of death during the 
follow-up period in all three sites (1.09, 95% CI: 1.00 to 1.19 
site 1; 1.29, 95% CI: 1.15 to 1.44 site 2; 1.27, 95% CI: 1.06 to 
1.54 site 3).
Conclusions Our findings indicate that in these three 
cohorts, the populations admitted to hospital-at-home 
and hospital differ. We cannot rule out the risk of residual 
confounding, as our analysis relied on an administrative 
data set and we lacked data on disease severity and type 
of hospitalised care received in the control cohorts.
IntrODuCtIOn  
Organising health systems to optimise the 
health outcomes of older people and contain 
costs is a priority as populations around the 
world age, and the demand for healthcare 
continues to rise. Despite a global policy 
emphasis on ‘care closer to home’1 and initia-
tives that seek to ease demand for hospital 
based healthcare, efforts to innovate and 
deliver healthcare services that provide an 
alternative to hospital admission for older 
people have been piecemeal and often lack a 
health system perspective. A lack of evidence 
to support decision-making has contributed 
to this. Avoiding admission to hospital by 
providing acute healthcare in people’s homes, 
often as a hospital outreach service, is one of 
the more popular service innovations and yet 
there is uncertainty around the effectiveness 
and cost-effectiveness of this form of care.2 
The use of administrative data to evaluate 
service delivery interventions has the poten-
tial to provide a simple and efficient mech-
anism to provide real-world evidence about 
policy-relevant service innovations, and 
embed evaluation into local decision-making. 
However, previous experience of using 
routine data in this area of research has 
been of mixed success due to a limited set of 
strengths and limitations of this study
 ► The study used a large dataset from three of the 
largest Health Boards in Scotland. 
 ► The retrospective cohort study has allowed infer-
ences from real world evidence. 
 ► Various sensitivity analyses helped to address un-
certainty in the results. 
 ► The major limitation of this type of non-randomised 
comparison is residual confounding. 
 ► The lack of data on quality of life, as well as use of 
subsequent health, social, community and informal 
care is a limitation.
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variables, missing data and the complexity of policy-rele-
vant questions that often require a broad and longer term 
perspective.3 Administrative healthcare data collected in 
Scotland is unique in that it is population based, with little 
missing data. The aim of this study was to use these data 
to compare the characteristics of populations from three 
Health Boards who used a geriatrician-led hospital-at-
home service with the population who received hospital 
care, and to assess the impact of these services on health-
care costs and mortality.
MethODs
setting
We used patient level data collected by three of the four-
teen Scottish Health Boards of all patients aged 64 years 
and older, and who were admitted (referred to as the index 
admission) to either geriatrician-led admission avoidance 
hospital-at-home or inpatient hospital between August 2014 
and December 2015 (17 months) in site 1 and site 2, and 
between January 2015 and December 2016 (24 months) 
in site 3. These services are commissioned by integrated 
health and social care boards that cover a population of 
almost 1.5 million in urban and rural areas. The Informa-
tion Service Division (ISD), part of National Health Service 
Scotland, deidentified, cleaned and linked individual 
patient records to derive activity and costs related to periods 
before and after the index admissions. We obtained signed 
release forms from each Board’s Caldicott guardian, and 
followed the ISD data sharing agreement.
Intervention
The three service models of hospital-at-home provided an 
admission avoidance function that provided an alterna-
tive to inpatient hospital care, and had similar structures 
and functions; the main differences were in the capacity 
of the services and the organisation of services for reha-
bilitation (box 1).
Data sources
Data were available for each person for 2 years prior to 
their index admission, and from the point of their index 
admission to 6 months after index discharge from hospi-
tal-at-home or hospital. Box 2 presents a full list of all vari-
ables included in the dataset. Figure 1 provides schematic 
box 1 Description of each service
hospital-at-home
The three hospital-at-home services are broadly similar, capacity 
ranged between 24 and 60 beds for the period of the analysis. Each is 
a geriatrician-led service that is supported by nurses (sometimes nurse 
practitioners) and therapy practitioners for the initial assessment; geri-
atricians and the multidisciplinary team review patients in their homes 
and meet daily (a virtual ward round) to discuss patient cases and agree 
actions. Rehabilitation is available within the existing team with onward 
referral to community rehabilitation as required, and in one site rehabil-
itation is accessed through a parallel community rehabilitation services. 
Out of hours emergency cover is provided by primary care out-of-hours. 
Patients are referred to the service from GPs, sometimes through a 
central referral number or via step down from the acute hospital. The 
service offers access to diagnostics such as radiology, and intravenous 
fluids, antibiotics and oxygen. Cases are discussed daily with the multi-
disciplinary team at the virtual ward round and daily management plans 
agreed. In one site, there is close working with the day hospital where 
patients can be referred for follow-up or for investigations. Patients ac-
cess investigations and treatment with the same speed as inpatients. 
The services support intravenous therapies in the home.
hospital
The provision of hospital based acute health services varied among 
the sites; in one site, there were three district general hospitals (1653 
beds) that provide acute health services to a mainly urban population 
of 652 230, with a total of 1653 beds; in site 2 a hospital (550 beds) 
provides acute healthcare to a population of 180 130; and in site 3 there 
are two district general hospitals (825 beds) that provide healthcare 
to a population of 358 900, and acute admissions are via one of the 
hospitals.
box 2 List of variables included in the dataset
Costs of accidents and emergency attendances,
Costs of acute day cases,
Costs of acute elective hospitalisation,
Costs of acute non-elective hospitalisation,
Costs of geriatric wards,
Costs of mental health wards,
Costs of outpatient visits,
Costs of prescribed medication,
Costs of (re)admission to hospital-at-home.
Primary ICD-10 codes on index discharge,
Secondary ICD-10 codes on index discharge,
Length of stay of the index admission,
Age on index admission,
Gender,
Scottish Index of Multiple Deprivation, 1 (most deprived) to 10 (most 
affluent),
Long-term conditions,
Date of death (if applicable).
Based on ICD-10 codes:
Cardiovascular disease (I60-I69, G45),
Chronic obstructive pulmonary disorder (J41-J44, J47),
Dementia (F00-F03, F05.1),
Diabetes (E10-E14),
Coronary heart disease (ICD10: I20-I25),
Heart failure (I500, I501, I509),
Renal failure (N03, N18, N19, I12, I13),
Epilepsy (G40, G41),
Asthma (J45, J46),
Atrial fibrillation (I48, MS, G35),
Cancer (C00-C97),
Arthritis (M05, M19, M45, M47, M460-M462, M464, M468, M469),
Parkinson’s (G20-G22),
Chronic liver disease (K711, K713, K714, K717, K754),
Congenital problems (Q00-Q99),
Diseases of blood and blood forming organs (D50-D89),
Other diseases of the digestive system (K00-K122, K130-K839, K85X, 
K860-K93),
Other endocrine metabolic diseases (E00-E07, E15-E35, E70-E90),
Admitted to hospital-at-home or hospital.
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examples of the differing calendar time periods studied 
before and after index admission for people admitted 
between August 2014 and December 2015 to hospital-at-
home (patients A and B) or hospital (patients C and D) in 
site 1. As this illustrates, the maximum follow-up period 
for each patient consisted of the period between index 
admission and index discharge and 6 months after index 
discharge. The data were collected via the data systems 
used in hospitals to collect patient data. Hospital-at-home 
activity data was submitted to ISD from the local systems 
of the three sites. The linked data set included acute 
inpatient, geriatric long stay and day case, mental health 
admissions, outpatient appointments accident and emer-
gency attendances, community prescribing and death 
registrations.
selection of patients in the hospital-at-home and control 
cohorts
We included patients aged 65 years and older, and who 
were classified as an unscheduled admission to general 
or geriatric medicine. In the control cohort, we excluded 
those with a diagnosis that would not be eligible for 
management through hospital-at-home; these exclu-
sions included acute intracerebral crisis (intracerebral 
infections, trauma or haemorrhage), stroke and related 
codes, acute coronary syndromes and myocardial infarc-
tion, surgical emergencies including vascular, urological, 
gynaecological and general surgical presentations, ortho-
paedic diagnosis of fractures and trauma, cardiothoracic 
diagnoses, poisoning and complications of surgery. We 
also excluded from the control group those who had a 
diagnosis (ie, primary and secondary International Classi-
fication of Diseases (ICD-10) code) that was not observed 
in any of the hospital-at-home admissions in each site 
(1081 patients in site 1, 1405 in site 2 and in 451 in site 3) 
(figure 2). Each patient was counted as a single episode 
of healthcare.
Intervention costs
We collected data on the costs of hospital-at-home using a 
template derived from the Cost-It tool of the WHO.4 The 
cost categories included staff, training, transport, infor-
mation and communication, clinical materials/equip-
ment, support services, laboratory services, diagnostics, 
overheads and other costs. Clinician managers supported 
by finance staff in the three Health Boards completed this 
template based on the actual spending for the hospital-
at-home service for the time periods covered by the ISD 
data. The cost per hospital-at-home admission was calcu-
lated by dividing the total costs of the hospital-at-home 
service by the total number of hospital-at-home admis-
sions during the same period.
statistical analysis
We used an iterative approach to the analysis, starting with 
a description of the two cohorts (ie, those admitted to 
hospital-at-home and those admitted to hospital) for each 
Health Board. We calculated means, SD and frequen-
cies to describe differences in patient characteristics at 
index admission and tested differences using two sample 
t-test and Mann-Whitney test for continues variables and 
χ2 test for categorical variables. We also estimated the 
mean differences in resource utilisation costs (with boot-
strapped SEs) and the unadjusted relative risk of mortality 
between the two cohorts for each Health Board.
Further, we investigated the association of being 
admitted to hospital-at-home or hospital with mortality 
and cost over a minimum follow-up period of 6 months. 
To do this, we followed the Medical Research Council 
guidelines on performing natural experiments and scien-
tific literature to adopt a stepwise strategy to select the 
propensity score matching (PSM) technique that most 
reduced observed confounding between the two cohorts 
in each Health Board.5–8 First, we included all possible 
confounding variables available in the dataset (see box 2 
Figure 1 Illustration of obtained data from site 1.
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and figure 2), and considered that the inclusion of covari-
ates not associated with the treatment assignment would 
have little influence in the propensity score model.5 
Second, we matched the two cohorts in each site using a 
range of the most commonly used PSM techniques; these 
included Mahalanobis, 1-to-1, K-to-1, kernel, local linear 
regression, spline and inverse probability weighting 
techniques. Second, the performance of each PSM tech-
nique on covariate balancing was assessed based on the 
mean and median percentage standardised bias as well 
as Rubin’s B (the absolute standardised difference of the 
means of the linear index of the propensity score in the 
treated and (matched) non-treated group) and Rubin’s 
R (the ratio of treated to (matched) non-treated vari-
ances of the propensity score index). Following Rubin’s 
(2001) recommendation, we considered B less than 25 
and R between 0.5 and 2 to indicate sufficient balance.9 
Third, we chose the PSM technique that had the lowest 
values on these performance indicators in each of the 
three Health Boards. We matched the two cohorts in 
each Health Board by sociodemographic characteristics 
(ie, age, gender, socioeconomic status), diagnosis code 
(ie, primary and secondary ICD-10 code) of index admis-
sion, morbidity (ie, type of long-term condition, mortality 
during follow-up (for the analysis of cost), 2-year costs 
prior to the index admission (by cost category as listed 
in box 1), and date of index admission (to account for 
seasonal trends).
We performed a doubly robust estimation to further 
reduce confounding by using a regression analysis 
after performing the most suitable PSM technique and 
including the confounding variables listed above as 
covariates.10 In the regression, we used generalised linear 
regression models (GLMs) with gamma distribution and 
log link to investigate the association of hospital-at-home 
with total costs during the follow-up period, and total 
costs in 6 months following index discharge. We also used 
GLMs with Poisson distribution and log link to estimate 
the relative risk of mortality. Robust SEs were specified 
in all regression models. We calculated Kaplan-Meier 
survival curves, with and without using the weights from 
the PSM, and used log-rank tests to test the equality of 
the survival functions. There were few missing observa-
tions in the dataset and thus, complete case analysis was 
performed.
subgroup analysis
We conducted a sub-group analysis, running the same 
regression models used in the main analysis, to investi-
gate the association of hospital-at-home services with 
costs and mortality for the population who had a diag-
nosis of dementia. We considered this population to be 
important due to their complex healthcare needs, and 
the increasing prevalence of dementia.11 12 In a second 
subgroup analysis, we excluded patients who died during 
the follow-up period and investigated the association of 
hospital-at-home with costs. In both subgroup analyses, 
PSM was performed to match sub-cohorts in each site.
sensitivity analysis
In a univariate sensitivity analysis, we reduced and 
increased the intervention cost of admission avoidance 
Figure 2 Flow chart of study population. ISD, Information Service Division.
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hospital-at-home by 50%, as there are no standard unit 
costs to benchmark these types of services and we were 
concerned that costs for these services may vary due to 
economies of scale, size, experience, setting, human 
resource capacity and error. This sensitivity analysis was 
expected to impact the costs during index admission 
and the costs of admission to hospital-at-home in the 
6 months after discharge. In another sensitivity analysis, 
we estimated the E-value to assess how strong unmea-
sured confounding would have to be with both the treat-
ment (ie, admission to hospital-at-home) and outcome 
(ie, costs and mortality) to fully explain away the esti-
mated treatment effects, conditional on the measured 
confounders.13 14
Patient involvement
Patients were not involved in this retrospective analysis of 
administrative data.
resuLts
Characteristics of the population cohorts
After applying the exclusion criteria, 1737 patients were 
admitted to hospital-at-home in site 1 between August 
2014 and December 2015 (17 months), 1463 patients were 
admitted to hospital-at-home in site 2 between January 
2015 and December 2016 (24 months), and 433 patients 
were admitted to hospital-at-home in site 3 between 
August 2014 and December 2015 (17 months) (figure 2). 
In the same period, there were 13 139 patients admitted 
to three hospitals in site 1, 3994 patients admitted to 
one hospital in site 2, and 1844 patients admitted to one 
hospital in site 3.
There were few differences between the hospital-at-
home cohorts in the three sites, the main difference being 
that a larger proportion of the population in site 2 lived in 
a more affluent area (ie, scored five or higher on the Scot-
tish Index of Multiple Deprivation). Patients admitted to 
hospital-at-home were on average three to 4 years older 
than those admitted to hospital, were more likely to 
be female (range from five percentage points to nine 
percentage points), and a higher proportion had more 
than four long-term conditions (approximately seven 
percentage points) compared with patients admitted to 
hospital (table 1). The largest difference between those 
admitted to hospital-at-home and to hospital in site 1 and 
site 2 was in the proportion of patients with dementia 
(10 percentage points higher in the hospital-at-home 
cohorts), while in site 3, it was the proportion of patients 
with renal failure (also 10 percentage points higher in the 
hospital-at-home cohort).
We compared the two cohorts in each site, from index 
admission to 6 months postdischarge from hospital-
at-home or hospital (table 2). There was on average a 
higher percentage of deaths while receiving healthcare 
in hospital compared with those receiving healthcare 
in hospital-at-home (6% vs 1%, site 1; 6% vs 3%, site 2; 
4% vs 1%, site 3); and a higher percentage of deaths in 
the follow-up period, from admission to 6 months after 
discharge, in the groups that had received hospital-at-
home (21% vs 28%, site 1; 22% vs 32%, site 2; 17% vs 
27%, site 3). Patients in the hospital-at-home cohort lived 
on average 8 (site 1), 10 (site 2) and 12 (site 3) fewer 
days during the whole follow-up, and their index admis-
sion was on average fewer days in site 1 (mean unadjusted 
difference −2.64, 95% CI −2.97 to −2.31) and site 3 (mean 
unadjusted difference −2.02, 95% CI −2.66 to −1.37) and 
longer in site 2 (mean unadjusted difference 1.25, 95% CI 
0.86 to 1.64).
The cost during a hospital-at-home admission was on 
average lower than hospital admission in site 1 (mean 
difference −£2318; 95% CI: £−2420 to £−2217) and site 3 
(mean difference −£1096; 95% CI: −£1398 to −£793), and 
slightly lower (mean difference −£153; 95% CI: −£277 to 
−£29) in site 2 (table 2). In the hospital-at-home cohort, 
these costs included the intervention costs of delivering 
the service at home, which were £628 per admission and 
£113 per day in site 1, £2928 per admission and £398 per 
day in site 2 and £864.54 per admission and £117.57 per 
day in site 3. In each Health Board, staff were the major 
driver of the cost of delivering hospital-at-home (site 1 
95%, site 2 87%, site 3 94%). Detailed information on the 
costs of delivering hospital at home are in online supple-
mentary appendix 1.
Each of the three hospital-at-home cohorts incurred 
higher healthcare costs, driven by non-elective hospital-
isation, prior to their index admission compared with 
the respective control cohort. Site 1 had on average 40% 
higher costs (mean difference £3219; 95% CI: £2513 to 
£3925), site 2 56% higher costs (mean difference £5064; 
95% CI: £3984 to £6143) and site 3 57% higher costs 
(mean difference £4115; 95% CI: £2467 to £5764). In the 
6 months following discharge from the index admission, 
costs were higher for each of the three hospital-at-home 
cohorts; in site 1 costs were on average 43% higher (mean 
difference £1839; 95% CI: £1423 to £2255), in site 2, they 
were 16% higher (mean difference £875, 95% CI: £156 
to £1595), and in site 3, they were 92% higher (mean 
difference £3068, 95% CI: £2178 to £3958). The larger 
increase in costs in all sites was due to higher non-elec-
tive hospitalisation costs in the group who had received 
hospital-at-home care (mean difference £1517, 95% CI 
£1134 to £1899 site 1; mean difference £529, 95% CI −£77 
to −£1135 site 2; mean difference £2618, 95% CI £1779 to 
£3458 site 3) during the 6 months follow-up.
When the cost of the index admission was included in 
the analysis, the cost during follow-up (ie, including the 
index admission and 6 months healthcare resource use 
after index discharge) was 6% lower (mean difference 
-£480, 95% CI: £−996 to £36) in the hospital-at-home 
cohort, compared with the control cohort in site 1; while 
these costs were 8% higher in site 2 (mean difference 
£722, 95% CI: £32 to £1413) and 35% higher in site 3 
(mean difference £1973, 95% CI: £1019 to £2927).
Compared with the control cohort, the mean costs per 
day of being alive during the follow-up period were 13% 
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(mean difference −£12; 95% CI: −£17 to −£6) lower in the 
hospital-at-home cohort in site 1, while these costs were 
34% higher (mean difference £37; 95% CI: £18 to £56) 
and 66% higher (mean difference £36; 95% CI: £18 to 
£53) in site 2 and site 3, respectively.
selection of PsM technique
In the propensity score matched analysis, there were 1696, 
925 and 427 patients in the hospital-at-home cohort and 
11571, 3849 and 1683 patients in the hospital cohort in 
site 1, site 2 and site 3, respectively (figure 2). Local linear 
regression matching was the best PSM technique to match 
the cohorts in site 1 and site 3 for costs and mortality, as 
it resulted in a lower mean (ie, 1.5 and 1.8 respectively) 
and median (ie, 1.2 and 1.6 respectively) percentage 
standardised bias, as well as the lowest Rubin’s B (ie, 9.4 
and 9.6 respectively). Based on the same criteria, Kernell 
matching was selected to match the cohorts in site 2. 
Rubin’s R was within the suggested range (ie, from 0.5 to 
2) in the selected techniques. These results as well as the 
patient characteristics at index admission after PSM are 
presented in online supplementary appendix 2. As this 
appendix shows, the differences in patient characteristics 
between the compared cohorts were almost eliminated 
after PSM.
Main propensity score matched analysis
The results of the main analysis are presented in panel A 
in table 3. After PSM and regression analysis, the health-
care cost for site 1 in hospital-at-home during the whole 
Table 1 Patient characteristics at index admission
Variable
Site 1 Site 2 Site 3
Control 
(n=13 139) HAH (n=1737)
Control 
(n=3994) HAH (n=1463)
Control 
(n=1844) HAH (n=433)
Mean age on admission 
(SD)
77.8 (7.78) 81.2 (7.21)** 78.5 (8.11) 82.2 (7.82)** 77.3 (7.81) 81.4 (7.12)**
Female 7468 (57%) 1096 (63%)** 2102 (53%) 909 (62%)** 1037 (56%) 266 (61%)*
Higher than four on the 
SIMD
5005 (38%) 609 (35%)** 1960 (49%) 775 (53%)* 837 (45%) 192 (44%)
More than four chronic 
conditions
4974 (38%) 777 (45%)** 1664 (42%) 725 (50%)** 659 (36%) 185 (43%)**
Arthritis 3431 (26%) 497 (29%)* 1455 (37%) 572 (39%) 606 (33%) 155 (36%)
Asthma 1370 (10%) 183 (11%) 497 (13%) 207 (14%) 177 (10%) 49 (11%)
Atrial fibrillation 3659 (28%) 488 (28%) 1555 (29%) 468 (32%)* 498 (27%) 126 (29%)
Cancer 3749 (29%) 485 (28%) 1261 (32%) 371 (25%)** 580 (31%) 124 (29%)
CVD 2922 (22%) 467 (27%)** 763 (19%) 392 (27%)** 373 (20%) 114 (26%)**
Liver disease 499 (4%) 50 (3%) 183 (5%) 52 (4%) 72 (4%) 20 (5%)
COPD 3641 (28%) 505 (29%) 1083 (27%) 428 (29%) 510 (28%) 132 (31%)
Dementia 1999 (15%) 439 (25%)** 665 (17%) 390 (27%)** 223 (12%) 74 (17%)**
Diabetes 2985 (23%) 403 (23%) 948 (24%) 350 (24%) 410 (22%) 115 (27%)*
Epilepsy 459 (4%) 75 (4%) 146 (4%) 78 (5%)** 53 (3%) 10 (2%)
CHD 5034 (38%) 733 (42%)** 1425 (36%) 575 (39%)* 624 (34%) 141 (33%)
Heart failure 2197 (17%) 404 (23%)** 744 (19%) 32 (23%)** 328 (18%) 109 (25%)**
MS 73 (1%) 6 (0%) 21 (1%) 17 (1%)* 14 (1%) 2 (1%)
Parkinson’s 293 (2%) 66 (4%)** 82 (2%) 53 (4%)** 53 (3%) 20 (5%)
Renal failure 2501 (19%) 394 (23%)** 780 (20%) 339 (23%)** 284 (15%) 110 (25%)**
Congenital problems 277 (2%) 38 (2%) 159 (4%) 51 (4%) 51 (3%) 9 (2%)
Diseases of blood 3784 (29%) 553 (32%)** 1143 (29%) 426 (29%) 485 (26%) 125 (29%)
Endocrine metabolic 
disease
4505 (34%) 624 (36%) 1737 (44%) 652 (45%) 642 (35%) 151 (35%)
Disease of digestive system 9341 (71%) 1249 (72%) 2710 (68%) 1006 (69%) 1145 (62%) 286 (66%)
A patient  could be registered with more than one ICD-10 codes.
SIMD ranges from 1 (most deprived) to 10 (most affluent).
*P<0.05; **P<0.01 in χ2 test for categorical and two sample t-test and Mann-Whitney test for continuous variables to test differences 
between HAH and control.
CHD, coronary heart disease COPD, chronic obstructive pulmonary disorder; CVD, cardiovascular disease; HAH, hospital-at-home; 
MS, multiple sclerosis; SIMD, Scottish Index of Multiple Deprivation.
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follow-up period (ie, during index admission and over 
6 months after discharge from the index admission) was 
on average 18% lower (ratio of means: 0.82; 95% CI: 0.76 
to 0.89) than admission to hospital. When the cost of the 
index admission was excluded from the hospital-at-home 
and hospital cohorts, costs were on average 27% higher 
(ratio of means: 1.27; 95% CI: 1.14 to 1.41) for hospital-
at-home compared with hospital in site 1. In site 2, the 
difference in costs between the hospital-at-home and 
hospital was close to zero (ratio of means: 1.00; 95% CI 
0.92 to 1.09) during the whole follow-up period and 
9% higher (although not statistically significant) (ratio 
of means: 1.09; 95% CI: 0.95 to 1.24) when the cost of 
the index admission was excluded. In site 3, patients 
admitted to hospital-at-home had on average 15% higher 
(although not statistically significant) cost during the 
whole follow-up period (ratio of means: 1.15; 95% CI 0.99 
to 1.33) and 70% higher cost when the cost of the index 
admission was excluded (ratio of means: 1.70; 95% CI 
1.40 to 2.07) compared with patients admitted to hospital. 
The full results of the regression analyses are presented in 
online supplementary appendix 3.
There may be an increased risk of mortality in all three 
hospital-at-home cohorts (site 1: relative risk 1.09; 95% CI 
1.00 to 1.19) (site 2: relative risk 1.29; 95% CI: 1.15 to 
1.44) (site 3: relative risk 1.27; 95% CI: 1.06 to 1.54) 
compared with the hospital cohort after PSM and regres-
sion were performed to adjust for confounding. The 
Kaplan-Meier survival curves presented in figure 3 show 
higher survival rates in the inpatient control cohorts in all 
three sites, and after weighting with the propensity score 
the control cohort in site 2 continued to have a higher 
survival rate than the hospital-at-home cohort. The differ-
ence in survival in site 3 between the results reported in 
table 3 and the survival curve after weighting is explained 
by the fact that Kaplan-Meier curves are only weighted 
with the propensity score without performing an addi-
tional regression analysis.
results of the subgroup analysis
Patients with dementia (Panel B in table 3) admitted 
to hospital-at-home services in site 1 and site 2 had an 
average of 24% lower costs (site 1: ratio of means 0.76; 
95% CI 0.66 to 0.87; site 2: ratio of means 0.76 95% CI: 
0.66 to 0.88) from the index admission to 6 months 
post-discharge. We found that the population who were 
admitted to hospital-at-home, and had a diagnosis of 
dementia, may have an increased risk of death (site 1: 
1.05, 95% CI 0.89 to 1.24; site 2: relative risk 1.41, 95% CI 
1.19 to 1.67; site 3: relative risk 1.65, 95% CI 1.12 to 2.41) 
compared with those who had a diagnosis of dementia 
and who were admitted to hospital.
When we excluded people who died during follow-up 
(ie, during index admission and 6 months after 
discharge), patients admitted to hospital-at-home in 
site 1 had lower costs (ratio of means 0.85, 95% CI: 0.77 
to 0.94), while there was 11% increase in costs in site 
2 (ratio of means 1.11, 95% CI: 1.00 to 1.25) and 20% V
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increase in site 3 (ratio of means 1.20, 95% CI: 1.00 to 
1.43); the mean costs were higher in the hospital-at-
home cohort when the costs during the index admis-
sion were excluded (site 1: ratio of means 1.23, 95% CI: 
1.08 to 1.40; site 2: ratio of means 1.17, 95% CI 0.99 to 
1.38; site 3: ratio of means 1.71, 95% CI 1.36 to 2.15) 
compared with patients admitted to hospital (Panel C 
in table 3).
results of the sensitivity analyses
The results from the sensitivity analysis (Panel D in table 3) 
showed that patients in the hospital-at-home cohort in site 
1 had 13% lower costs (ratio of means 0.87; 95% CI: 0.81 
to 0.94) during the follow-up period (ie, during index 
admission and 6 months after index discharge) when the 
hospital-at-home service costs were assumed to be 50% 
higher than in the main analysis. In site 2, the results 
from the sensitivity analysis showed that the uncertainty 
in hospital-at-home service costs lead to increased costs or 
cost savings by about 18% (ratio of means 1.18; 95% CI: 
1.09 to 1.28) during the whole follow-up period. In site 3, 
the sensitivity analysis showed a 23% cost increase (ratio 
of means 1.23; 95% CI: 1.07 to 1.42), if the intervention 
costs of hospital-at-home were 50% higher. The estimated 
e-values are presented in online supplementary appendix 
4 and show that unmeasured confounders should be 
strongly associated with admission to hospital-at-home 
as well as with costs and mortality after adjusting for the 
observed confounders in order to explain away the results 
of the main analysis.
DIsCussIOn
Main findings
Patients who received healthcare from the hospital-at-
home services were older, were more socioeconomically 
Table 3 Results of the propensity score matched regression analyses
Panel A: main analysis
Outcome variable Site 1 (n=13 267) Site 2 (n=4769) Site 3 (n=2110)
Total costs during follow-up 
period*
0.82 (0.03) [0.76 to 0.89]<0.001 1.00 (0.05) [0.92 to 1.09] 0.982 1.15 (0.09) [0.99 to 1.33] 0.073
Total costs in 6 months after 
discharge
1.27 (0.07) [1.14 to 1.41]<0.001 1.09 (0.07) [0.95 to 1.24] 0.219 1.70 (0.17) [1.40 to 2.07]<0.001
Mortality rate during follow-up 1.09 (0.05) [1.00 to 1.19] 0.059 1.29 (0.07) [1.15 to 1.44]<0.0010 1.27 (0.12) [1.06 to 1.54] 0.011
Panel B: subgroup analysis including only patients with dementia
Outcome variable Site 1 (n=2321) Site 2 (n=1053) Site 3 (n=280)
Total costs during follow-up 
period*
0.76 (0.05) [0.66 to 0.87]<0.001 0.76 (0.06) [0.66 to 0.88]<0.001 0.87 (0.15) [0.63 to 1.21] 0.409
Total costs in 6 months after 
discharge
1.18 (0.11) [0.99 to 1.41] 0.071 0.75 (0.09) [0.59 to 0.96] 0.021 1.58 (0.41) [0.95 to 2.63] 0.078
Mortality rate during follow-up 1.05 (0.09) [0.89 to 1.24] 0.594 1.41 (0.12) [1.19 to 1.67]<0.001 1.65 (0.32) [1.12 to 2.41] 0.011
Panel C: subgroup analysis including only survivors
Outcome variable Site 1 (n=10 132) Site 2 (n=3584) Site 3 (n=1691)
Total costs during follow-up 
period*
0.85 (0.04) [0.77 to 0.94] 0.002 1.11 (0.03) [1.00 to 1.25] 0.058 1.20 (0.11) [1.00 to 1.43] 0.046
Total costs in 6 months after 
discharge
1.23 (0.08) [1.08 to 1.40] 0.002 1.17 (0.10) [0.99 to 1.38] 0.070 1.71 (0.20) [1.36 to 2.15]<0.001
Panel D: sensitivity analysis
Outcome variable Site 1 (n=13 267) Site 2 (n=4769) Site 3 (n=2110)
Total costs during follow-up 
period*
(assuming 50% lower 
intervention costs)
0.77 (0.03) [0.71 to 0.84]<0.001 0.81 (0.04) [0.74 to 0.9] 0.001 1.07 (0.09) [0.91 to 1.25] 0.399
Total costs during follow-up 
period*
(assuming 50% higher 
intervention costs)
0.87 (0.03) [0.81 to 0.94] 0.001 1.18 (0.05) [1.09 to 1.28]<0.001 1.23 (0.09) [1.07 to 1.42] 0.004
The results are presented as coefficient (SE) (95% CI) p value. The results are after matching and adjusting for age, gender, 
socioeconomic status, primary and secondary ICD-10 codes of index admission, type of long-term condition, mortality (for the 
analysis of costs), 2-year costs prior to the index admission (by cost category as listed in box 1).
 *It includes the index admission period and  6 months  postdischarge. 
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disadvantaged, had higher morbidity (measured by the 
number of long term conditions), higher rates of previous 
hospitalisation and there was a greater proportion of 
women compared with the group admitted to hospital. 
The two groups also differed in terms of their clinical 
diagnosis, with the most marked difference across the 
three services being a greater percentage (5%–10% differ-
ence) of people with dementia. The higher healthcare 
costs over the 2 years prior to index admission in those 
admitted to hospital-at-home were mainly driven by the 
Figure 3 Survival curves before and after propensity score matching. HAH, hospital-at-home.
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costs of non-elective hospitalisation. However, the differ-
ences in patient characteristics were almost eliminated 
after PSM. The cost of providing hospital-at-home varied 
between the three sites from £628 to £2928 per admission, 
and costs were driven primarily by staff costs. Our findings 
indicate that hospital-at-home might be associated with an 
increase in healthcare costs in the 6 months after index 
discharge. However, this increase in costs might be offset 
by likely cost-savings during the index admission. The 
higher healthcare cost at 6 months after index discharge, 
was driven primarily by acute non-elective hospitalisation. 
Interpreting this is not straightforward; it might indicate 
a lack of resources during the index admission to hospi-
tal-at-home, or an increased risk of hospital admission 
in the population who receive their healthcare through 
hospital-at-home. The suggestion of an increased risk of 
mortality at 6 months after the index admission might be 
genuine, or could indicate that PSM did not control for 
all differences between the groups and thus, the estimates 
are subject to residual confounding.15 16
Comparison with previous studies
A meta-analysis of six small randomised controlled trials 
concluded that admission avoidance hospital-at-home 
probably makes little or no difference to the risk of 
death or transfer to hospital at 6 months' follow-up, and 
might increase the likelihood of living at home (although 
with low-certainty evidence); and highlighted the lack 
of evidence on cost.2 Studies that have used ‘real life 
data’ offer the potential to address criticisms of limited 
external validity from randomised trials; and PSM is one 
technique that has been used to balance co-variates when 
analysing routinely collected health data to assess these 
type of service delivery interventions. Findings have been 
consistent, and previous studies have reported higher 
rates of mortality and unplanned admission for those who 
received an intermediate care intervention, compared 
with matched controls.6 16 17 However, it is possible that 
these findings are subject to residual confounding.
Potential mechanisms and interpretation
Healthcare services that cross the interface of primary and 
secondary care can bridge and strengthen the integration 
of acute and community services, and social care. However, 
by definition this can lead to a complex arrangement of 
services that reflect availability of local resources,18 and 
a willingness to innovate. The hospital-at-home services 
evaluated in this analysis were established to reduce the 
demand for acute hospital beds by providing an alterna-
tive to admission to hospital, and to lower the risk of func-
tional decline from the limited mobility that older people 
might experience when in hospital. However, it is possible 
that the services have several functions, for example by 
providing both rapid response and reablement, and this 
is reflected in the diverse population included in this 
analysis. Existing services and the overall structure of the 
healthcare care system in Scotland may also have influ-
enced the shape and scope of hospital-at-home functions. 
Regarding the control cohorts, older people admitted to 
acute hospital in Scotland receive quite variable care and 
access to comprehensive geriatric assessment depending 
on whether they are placed in a geriatric medical unit 
or other environments such as general adult medicine. 
This variation may also have influenced the results of this 
study.
Implications for clinicians and policy-makers
The variation in intervention costs of the three hospi-
tal-at-home services is primarily driven by staff costs, 
and the findings of the sensitivity analysis confirms that 
staff costs are likely to determine whether a hospital-at-
home service leads to higher costs or cost savings. The 
skill-mix of healthcare professionals who provide hospi-
tal-at-home should be guided by national standards, the 
type of patients the service targets and the function of 
the service in terms of whether or not the service supple-
ments existing community based healthcare, substitutes 
for hospital level care, augments palliative care services 
or a combination of these. The integration of these 
types of service with existing primary and secondary care 
services, for example the provision of out-of-hours care 
by primary care services, might also determine the costs 
of these services. Managerial capacity of these services is 
expected to be of crucial importance in setting-up and 
managing the team of professionals able to provide high 
quality care.
The absence of evidence based guidelines about who 
and under which conditions a patient may be admitted 
to admission avoidance hospital-at-home might explain 
the variation in the set-up of services, the difference in 
patient characteristics between patients admitted to 
hospital-at-home and hospital, and the relatively small size 
of the services. This is confirmed by the National Audit 
of Intermediate Care,19 that was established in response 
to concerns about governance structures in intermediate 
care services, and reported a complex pattern of service 
provision.
Data on the role and capability of informal care givers 
is largely absent. In many cases, people admitted to hospi-
tal-at-home services receive care from their partners who 
if old might have health issues themselves.
strengths and limitations
The strengths of this study include the dataset from three 
of the largest Health Boards in Scotland, the quasi-exper-
imental study design that has allowed inferences from 
real world evidence, and the sensitivity analyses that 
helped to address uncertainty in the results. The major 
limitation of this type of non-randomised comparison is 
residual confounding. While matching individuals and 
performing regression analysis can reduce this risk, it is 
possible that the two populations differed in frailty because 
we did not match and adjust for differences in the use of 
community and social services prior to index admission. 
If unobserved confounders were part of the clinical-deci-
sion making by GPs and geriatricians to admit patients to 
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hospital-at-home or hospital, our findings might be biased 
due to confounding by clinical indication. This type of 
confounding is often not measured directly because stan-
dardised criteria are not available to guide clinical deci-
sion-making.20 21 Therefore, the magnitude of this bias 
in our results depends on the clinical-decision making 
process to admit patients to hospital-at-home in the three 
sites. If clinicians did not consider hospital-at-home as a 
substitute service to hospitalisation then confounding by 
indication would increase the residual confounding in our 
analysis. GPs and geriatricians who refer patients to hospi-
tal-at-home are likely to have a clinical bias in preferring 
to keep older, frailer and terminally ill patients in their 
own home. Using hospital-at-home admission criteria to 
define the control cohort accepts that such open criteria 
will include general medical patients who are likely to 
have fewer comorbidities, be younger and with a longer 
life expectancy. However, as the results of the survivors’ 
subgroup analysis were very similar with the results of the 
main cost analysis we expect that the magnitude of the 
residual confounding to be small. Furthermore, the use 
of routine data has been used to reliably identify older 
people with frailty,22 and approaches using clinical codes 
to define this population are being tested.23
Future research
Guidance on the use of real life data to evaluate service 
delivery interventions is largely absent, and could provide 
healthcare decision-makers with a relatively inexpensive 
way of evaluating local service innovations and how to 
avoid pitfalls in analysis and interpretations. Similar to 
all observational studies, the findings of this study may 
be used to identify important questions to be tested in 
randomised trials.20 A multicentre randomised trial 
that measures outcomes that are key to decision-makers 
(including informal care giving), and is accompanied by 
a process evaluation to help explain the findings, is neces-
sary to provide clinicians and policy-makers with further 
evidence about the effectiveness and cost-effectiveness 
of admission avoidance hospital-at-home services across 
UK. The authors are involved in such a trial the results of 
which are expected to be available in 2019.24
COnCLusIOns
We found differences in the populations admitted to 
hospital-at-home and hospital. The likely higher cost in 
all three hospital-at-home cohorts, compared with the 
hospital cohorts during the 6 months following discharge, 
highlights the importance of characterising populations 
eligible to receive these types of healthcare services and 
of assessing subsequent use of health, social and informal 
care following admission to hospital-at-home or hospital. 
The lack of data on the severity of the observed acute and 
chronic conditions as well as on type of hospitalised care 
received in the control cohorts means that we cannot rule 
out the risk of residual confounding, and the findings 
should be interpreted with caution.
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